{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:36:19Z","timestamp":1787582179492,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC3403200"],"award-info":[{"award-number":["2023YFC3403200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFF1503100"],"award-info":[{"award-number":["2024YFF1503100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jconrel.2026.115087","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T16:35:17Z","timestamp":1781541317000},"page":"115087","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cascade active-targeting nanoplatform via multi-ligand regulation for spleen-selective mRNA delivery"],"prefix":"10.1016","volume":"396","author":[{"given":"Xi","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongshan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangrong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jconrel.2026.115087_bb0005","article-title":"Nucleic acid drug and delivery techniques for disease therapy: present situation and future prospect","volume":"2","author":"Wang","year":"2024","journal-title":"Interdiscipl. Med."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115087_bb0010","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1992","article-title":"Insights into the formulation of lipid nanoparticles for the optimization of mRNA therapeutics","volume":"16","author":"Jiao","year":"2024","journal-title":"WIREs Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.115087_bb0015","article-title":"Albumin-recruiting lipid nanoparticle potentiates the safety and efficacy of mRNA vaccines by avoiding liver accumulation","author":"Feng","year":"2025","journal-title":"Nat. Mater."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115087_bb0020","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41392-022-01007-w","article-title":"mRNA-based therapeutics: powerful and versatile tools to combat diseases","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115087_bb0025","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2020.12.014","article-title":"Self-assembled mRNA vaccines","volume":"170","author":"Kim","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115087_bb0030","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41571-024-00902-1","article-title":"Cancer mRNA vaccines: clinical advances and future opportunities","volume":"21","author":"Sayour","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"22","key":"10.1016\/j.jconrel.2026.115087_bb0035","doi-asserted-by":"crossref","first-page":"15085","DOI":"10.1021\/jacs.4c00451","article-title":"Multicomponent synthesis of imidazole-based ionizable lipids for highly efficient and spleen-selective messenger RNA delivery","volume":"146","author":"Dong","year":"2024","journal-title":"J. Am. Chem. Soc."},{"issue":"35","key":"10.1016\/j.jconrel.2026.115087_bb0040","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abi6326","article-title":"A splenic-targeted versatile antigen courier: iPSC wrapped in coalescent erythrocyte-liposome as tumor nanovaccine","volume":"7","author":"Zhai","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115087_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2026.114680","article-title":"Large and low-PEG lipid nanoparticles enable efficient dendritic cell targeting for potent mRNA Cancer vaccines","volume":"392","author":"Xu","year":"2026","journal-title":"J. Control. Release"},{"issue":"45","key":"10.1016\/j.jconrel.2026.115087_bb0050","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202404684","article-title":"Discovery of ketal-Ester ionizable lipid nanoparticle with reduced hepatotoxicity, enhanced spleen tropism for mRNA vaccine delivery","volume":"11","author":"Lv","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.115087_bb0055","first-page":"429","article-title":"Splenic dendritic cell-targeting mRNA transfection of H-type ionizable lipid-based LNPs for enhancing tumor immunotherapy","volume":"61","author":"Chen","year":"2026","journal-title":"Bioact. Mater."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115087_bb0060","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"issue":"20","key":"10.1016\/j.jconrel.2026.115087_bb0065","doi-asserted-by":"crossref","first-page":"12181","DOI":"10.1021\/acs.chemrev.1c00244","article-title":"Lipids and lipid derivatives for RNA delivery","volume":"121","author":"Zhang","year":"2021","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2026.115087_bb0070","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jconrel.2024.10.028","article-title":"Paracyclophane-based ionizable lipids for efficient mRNA delivery in vivo","volume":"376","author":"Wu","year":"2024","journal-title":"J. Control. Release"},{"issue":"9","key":"10.1016\/j.jconrel.2026.115087_bb0075","doi-asserted-by":"crossref","first-page":"9596","DOI":"10.1021\/jacs.5c20438","article-title":"Unraveling the role of ionizable lipid isomerism in modulating lipid nanoparticles for mRNA delivery","volume":"148","author":"He","year":"2026","journal-title":"J. Am. Chem. Soc."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115087_bb0080","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.3390\/pharmaceutics16121521","article-title":"Effect of lipid nanoparticle Physico-chemical properties and composition on their interaction with the immune system","volume":"16","author":"Catenacci","year":"2024","journal-title":"Pharmaceutics"},{"issue":"45","key":"10.1016\/j.jconrel.2026.115087_bb0085","doi-asserted-by":"crossref","first-page":"41756","DOI":"10.1021\/jacs.5c13982","article-title":"Fluorinated ionizable lipids for efficient spleen-targeted mRNA delivery in Cancer immunotherapy","volume":"147","author":"Zhang","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115087_bb0090","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"issue":"52","key":"10.1016\/j.jconrel.2026.115087_bb0095","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109256118","article-title":"On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles","volume":"118","author":"Dilliard","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.115087_bb0100","article-title":"PEG-free monosialoganglioside lipid nanoparticles with spleen-selective mRNA delivery for cancer immunotherapy","author":"Wang","year":"2025","journal-title":"Adv. Funct. Mater."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115087_bb0105","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/s41565-025-01954-9","article-title":"A versatile antibody capture system drives specific in vivo delivery of mRNA-loaded lipid nanoparticles","volume":"20","author":"Chen","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115087_bb0110","doi-asserted-by":"crossref","DOI":"10.1038\/s41565-025-02113-w","article-title":"Biomimetic vesicles engineered from modified tumour cells act as personalized vaccines for post-surgical cancer immunotherapy","author":"Yu","year":"2026","journal-title":"Nat. Nanotechnol."},{"issue":"10","key":"10.1016\/j.jconrel.2026.115087_bb0115","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202216836","article-title":"Spleen-targeted neoantigen DNA vaccine for personalized immunotherapy of hepatocellular carcinoma","volume":"15","author":"Wu","year":"2023","journal-title":"EMBO Mol. Med."},{"issue":"10","key":"10.1016\/j.jconrel.2026.115087_bb0120","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaw6870","article-title":"Red blood cell\u2013derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy","volume":"5","author":"Han","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115087_bb0125","article-title":"Deciphering the biological fate of mRNA-LNP-based biologics: a perspective from tissue to intracellular distribution","author":"Xu","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"8","key":"10.1016\/j.jconrel.2026.115087_bb0130","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-viral vectors for gene-based therapy","volume":"15","author":"Yin","year":"2014","journal-title":"Nat. Rev. Genet."},{"issue":"32","key":"10.1016\/j.jconrel.2026.115087_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202011068","article-title":"mRNA-loaded lipid-like nanoparticles for liver base editing via the optimization of central composite design","volume":"31","author":"Zheng","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2026.115087_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jare.2026.01.070","article-title":"Biomimetic and personalized nanovaccines in cancer immunotherapy: design innovations, translational challenges, and future directions","author":"Xu","year":"2026","journal-title":"J. Adv. Res."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115087_bb0145","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of mice and not men: differences between mouse and human immunology","volume":"172","author":"Mestas","year":"2004","journal-title":"J. Immunol."},{"issue":"33","key":"10.1016\/j.jconrel.2026.115087_bb0150","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aau6085","article-title":"Structure and function of the immune system in the spleen","volume":"4","author":"Lewis","year":"2019","journal-title":"Sci. Immunol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926004906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926004906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:55:11Z","timestamp":1787579711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926004906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":30,"alternative-id":["S0168365926004906"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115087","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cascade active-targeting nanoplatform via multi-ligand regulation for spleen-selective mRNA delivery","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115087"}}